Literature DB >> 7494411

Carrier screening in the community.

D J Brock1.   

Abstract

A number of different models of cystic fibrosis (CF) carrier screening have now been tested in pilot trials. Apart from opportunistic and cascade testing (which are strictly speaking not true forms of screening), the major programmes have been directed either to young adults in primary care or to pregnant women in antenatal clinics. Only in the latter form of screening has sufficient data been collected to allow conclusions to be reached on the optimum mode of delivery. It seems very probable that when CF carrier screening passes into routine service, it will be the antenatal couple model that is used.

Entities:  

Mesh:

Year:  1995        PMID: 7494411     DOI: 10.1007/bf00710064

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  Cystic fibrosis carrier screening by DNA analysis: a pilot study of attitudes among participants.

Authors:  F Kaplan; C Clow; C R Scriver
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

2.  Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

3.  Cascade testing for the identification of carriers of cystic fibrosis.

Authors:  S Holloway; D J Brock
Journal:  J Med Screen       Date:  1994-07       Impact factor: 2.136

4.  Uptake of cystic fibrosis testing in primary care: supply push or demand pull?

Authors:  H Bekker; M Modell; G Denniss; A Silver; C Mathew; M Bobrow; T Marteau
Journal:  BMJ       Date:  1993-06-12

5.  A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.

Authors:  S Zeesman; C L Clow; L Cartier; C R Scriver
Journal:  Am J Med Genet       Date:  1984-08

6.  Screening for carriers of cystic fibrosis among pregnant women: a pilot study.

Authors:  M Schwartz; N J Brandt; F Skovby
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

7.  Screening for carriers of cystic fibrosis through primary health care services.

Authors:  E K Watson; E Mayall; J Chapple; M Dalziel; K Harrington; C Williams; R Williamson
Journal:  BMJ       Date:  1991-08-31

8.  Antenatal screening for cystic fibrosis: a trial of the couple model.

Authors:  J Livingstone; R A Axton; A Gilfillan; M Mennie; M Compton; W A Liston; A A Calder; A J Gordon; D J Brock
Journal:  BMJ       Date:  1994-06-04

9.  Active cascade testing for carriers of cystic fibrosis gene.

Authors:  M Super; M J Schwarz; G Malone; T Roberts; A Haworth; G Dermody
Journal:  BMJ       Date:  1994-06-04

10.  Beta-thalassemia disease prevention: genetic medicine applied.

Authors:  C R Scriver; M Bardanis; L Cartier; C L Clow; G A Lancaster; J T Ostrowsky
Journal:  Am J Hum Genet       Date:  1984-09       Impact factor: 11.025

View more
  3 in total

1.  Diagnostic uses of DNA analysis: powerful but problematic.

Authors: 
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

Review 2.  The new genetics. Implications for clinical services in Britain and the United States.

Authors:  A L Kinmonth; J Reinhard; M Bobrow; S Pauker
Journal:  BMJ       Date:  1998-03-07

Review 3.  Cystic fibrosis: five years beyond the gene.

Authors:  D J Porteous
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.